Aistarfish Healthcare

Zhejiang Haixin Zhihui Technology Co., Ltd. develops an artificial intelligence system for cancer diagnosis and treatment, using Chinese guidelines to provide personalized recommendations and support care planning and management.

Haixin Health focuses on serving cancer patients, providing care and services throughout the course of their illness. It offers consultations, multidisciplinary consultations, monitoring, and other tailored services before, during, and after treatment to improve treatment outcomes.

ACXEL (Aosu Tech), operating as acx INSTRUMENTS, ranks first in the growth enterprise category of Cyzone/36Kr’s 2025 China Enterprise Globalization New Forces 100 list. The selection cites the company’s global strategy, technological innovation, and influence in overseas markets as reasons for its recognition.

Jul 2025 · Cyzone / 创业邦 via QimingNews article

Pharmaron's subsidiary completes a controlling acquisition of Zhejiang Haixin Zhihui (Aistarfish). The acquisition centers on its AI-powered tumor patient management platform, intended to enhance data and AI in CRO services.

Feb 2025 · Pharmaron / ByDrugNews article

Aistarfish, an intelligent case management platform for tumors, receives B2-round funding from Tailong Investment, BE-TOP Resources, and Zhenghe Benyuan. Founded in 2018, the company’s services reach 30 provinces and 600 hospital departments, with 100,000 patients served.

May 2022 · EqualOceanNews article